AHS, government must hand over records in Mentzelopoulos case, judge rules - CBC
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
CalgaryA judge ordered Alberta Health Services and the province to produce records to fill "certain gaps and deficiencies" tied to a lawsuit launched by the former CEO of AHS. Records ‘very important’ to Mentzelopoulos’ claims: lawyerJoel Dryden · CBC News · Posted: Oct 05, 2026 6:22 PM EDT | Last Updated: October 5Listen to this articleEstimated 4 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Athana Mentzelopoulos, former CEO of Alberta Health Services, is suing the provincial government and AHS for wrongful dismissal. She is seen outside the law courts in Edmonton on April 29. (Lisa Johnson/The Canadian Press)A judge has ordered Alberta Health Services and the province to produce records to fill "certain gaps and deficiencies" tied to a lawsuit launched by the former CEO of AHS. In February 2025, Athana Mentzelopoulos filed a $1.7-million lawsuit for wrongful dismissal against AHS and the provincial government.
This article is an excerpt. To read the full content, visit the original source. CBC
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!